MB
MPM Bioventures 2018, L.P. sold $616K of TRDA stock
MPM Bioventures 2018, L.P., 10% owner of Entrada Therapeutics, Inc. (TRDA), sold 86,914 shares of TRDA stock worth $616K, per an SEC Form 4 filed Aug 31, 2026.
It was an open-market sale.
The trade happened on Aug 27, 2026, 4 days before it was made public.
TRDA has moved -36.2% since the trade date, from $7.27 to $4.64 (Nov 19, 2026 close).
- Traded
- Aug 27, 2026
- Disclosed
- Aug 31, 2026
- Filing delay
- 4 days
- Price since
- -36.2%
- Role
- 10% owner
- Source
- SEC Form 4
More TRDA insider and Congress trades
- SellTRDA · MPM Bioventures 2018, L.P.$1.9MSep 9, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$1.9MSep 9, 2026
- SellTRDA · MPM Bioventures 2018, L.P.$617KSep 3, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$617KSep 3, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$616KAug 31, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$462KAug 27, 2026